Encyclopedia of contested claims
Home Browse Health & medicine Does cannabis use increase the...
Contested claim · Health & medicine · §0035

Does cannabis use increase the risk of psychosis?

Current evidence indicates that cannabis use is associated with a higher risk of psychotic experiences and psychotic disorders, especially with frequent use, early initiation, and high-THC products. The size of the risk varies across individuals and studies, and cannabis is one of several factors that may contribute to psychosis risk.

Reviewed by 10 models · 3 countries 13 curated references 23 revisions Updated 17 hours ago 5 min read

Panel verdict

9/10 agreement 90% confidence 0% spread 30 May 2026 filed

9 reviewing models concluded the claim is not supported by the available evidence.

The Adjudged panel has not yet completed its full review of this claim. This draft summarizes the main lines of evidence, key uncertainties, and candidate sources for later evaluation by reviewers.

Panel synthesis
Consensus & disagreement

Where the panel agreed

9 of 10 modelsThe claim is that cannabis use increases the risk of psychosis. In this context, psychosis can include hallucinations, delusions, disorganized thinking, or a diagnosed psychotic di...
9 of 10 modelsLarge observational studies and systematic reviews generally report an association between cannabis use and later psychotic symptoms or psychotic disorders. Many studies find that...
9 of 10 modelsOne major uncertainty is causality in individual cases. People who later develop psychosis may be more likely to use cannabis for reasons related to early symptoms, stress, social...

Where the panel diverged

No material disagreement was detected beyond minor differences in wording and confidence.

Why this question matters

Current evidence indicates that cannabis use is associated with a higher risk of psychotic experiences and psychotic disorders, especially with frequent use, early initiation, and high-THC products. The size of the risk varies across individuals and studies, and cannabis is one of several factors that may contribute to psychosis risk.

The claim being judged

The claim is that cannabis use increases the risk of psychosis. In this context, psychosis can include hallucinations, delusions, disorganized thinking, or a diagnosed psychotic disorder such as schizophrenia-spectrum illness.

The question is not whether every person who uses cannabis will develop psychosis. Most people who use cannabis do not develop a psychotic disorder. The issue is whether cannabis use changes the probability of psychosis at a population level or among higher-risk groups.

The claim also depends on patterns of use. Research often distinguishes occasional use from daily or near-daily use, adolescent use from adult-onset use, and lower-potency cannabis from high-THC cannabis products.

What the evidence shows

Large observational studies and systematic reviews generally report an association between cannabis use and later psychotic symptoms or psychotic disorders. Many studies find that the association remains after adjusting for some confounders, though observational research cannot remove every possible alternative explanation.

A dose-response pattern is commonly reported: heavier and more frequent cannabis use is associated with greater psychosis risk than occasional use. Studies also suggest that high-potency cannabis, particularly products with high THC concentration, may be associated with higher risk than lower-potency products.

There is evidence that age and vulnerability matter. Cannabis use during adolescence or young adulthood, when the brain is still developing and when many psychotic disorders first emerge, is often linked to higher risk. People with a personal or family history of psychosis, or other psychiatric risk factors, may be more vulnerable.

The evidence is strongest for cannabis as a risk factor or contributing factor rather than as a sole cause. Psychosis is multifactorial, involving genetics, environment, trauma, other substance use, social factors, and biological susceptibility.

Where uncertainty remains

One major uncertainty is causality in individual cases. People who later develop psychosis may be more likely to use cannabis for reasons related to early symptoms, stress, social environment, or other risk factors. Researchers attempt to address this, but residual confounding remains possible.

There is also uncertainty about product composition. Modern cannabis markets include widely varying THC and CBD concentrations, concentrates, edibles, and synthetic cannabinoids. Studies from earlier periods may not fully reflect current patterns of use.

Risk estimates also vary by population. The absolute risk for a low-risk adult who uses cannabis infrequently may be different from the risk for a teenager using high-THC cannabis daily or a person with a family history of psychosis.

The three parts of the claim

The umbrella claim is actually several claims bundled into one. Each needs its own evaluation.

PART 1 / 3
Cannabis use is associated with an increased risk of psychotic experiences or psychotic disorders compared with non-use.
Yes86%
PART 2 / 3
More frequent cannabis use and higher-THC products are associated with greater psychosis risk than occasional or lower-potency use.
Yes82%
PART 3 / 3
Cannabis use alone is sufficient to explain most cases of psychosis.
Not supported78%

Model comparison

How each panel model rated the three parts of the claim
Model Part 1 Part 2 Part 3 Overall
Grok 4.3 No · 86% No · 82% No · 78% No · 90%
OpenAI GPT-5.4 No · 86% No · 82% No · 78% No · 90%
Mistral Medium 3.5 No · 86% No · 82% No · 78% No · 90%
Llama 4 Maverick No · 86% No · 82% No · 78% No · 90%
Claude Opus 4.7 No · 86% No · 82% No · 78% No · 90%
Gemini 3.1 Pro No · 86% No · 82% No · 78% No · 90%
Qwen 3.7 Max No · 86% No · 82% No · 78% No · 90%
DeepSeek V4 Pro No · 86% No · 82% No · 78% No · 90%
GLM 5.1 No · 86% No · 82% No · 78% No · 90%
Kimi K2.6 Incomplete
An honest commitment

What would change our mind

The current evidence leans one way. But we're not committed to the conclusion, we're committed to the evidence.

  • Large longitudinal studies with stronger control of confounding that find no association between cannabis exposure and later psychosis across frequency and potency levels.
  • Consistent evidence that apparent cannabis-psychosis associations are fully explained by reverse causation, genetic liability, tobacco use, other substances, or social factors.
  • High-quality studies showing that THC potency and frequency of use do not meaningfully change psychosis risk.
  • Improved clinical or biomarker evidence clarifying which individuals are vulnerable or not vulnerable to cannabis-associated psychosis.
  • Updated systematic reviews incorporating modern high-potency cannabis markets that materially revise current risk estimates.

Common questions

Does cannabis cause schizophrenia?
The evidence supports cannabis as a risk factor for psychosis, including schizophrenia-spectrum outcomes, but psychosis usually has multiple contributing causes. Genetics, early life experiences, other substances, stress, and social factors can all affect risk.
Is the risk the same for occasional and daily cannabis use?
The risk does not appear to be the same. Studies commonly report higher risk among people who use cannabis frequently, especially daily or near-daily, compared with occasional users.
Does THC potency matter?
Evidence suggests that high-THC products may be associated with greater psychosis risk than lower-potency cannabis. The balance of THC and CBD may also matter, but product composition is often inconsistently measured in studies.
Who may be at higher risk?
People with a personal or family history of psychosis, adolescents and young adults, and people using high-potency cannabis frequently may face higher risk. Individual risk varies, so clinical guidance is especially important for people with psychiatric vulnerability.

References

Group

NASEM 2017 The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research National Academies of Sciences, Engineering, and Medicine Major evidence review summarizing cannabis-related health outcomes, including mental-health findings.
WHO 2016 The Health and Social Effects of Nonmedical Cannabis Use World Health Organization International public-health review discussing cannabis use and psychosis risk.

Government

NASEM 2017 The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research National Academies Press Major evidence review summarizing cannabis-related health outcomes, including mental health and psychosis.
NIDA Cannabis Cannabis and Hallucinogen Use and Mental Health National Institute on Drug Abuse U.S. federal health information on cannabis, including mental health risks and research context.
NIDA Cannabis Cannabis and Hallucinogen Use and Mental Health National Institute on Drug Abuse U.S. government research overview with discussion of cannabis and mental-health risks.
NHS Cannabis Cannabis: The Facts NHS Patient-facing health guidance that discusses cannabis use and possible mental-health effects.

Intergovernmental

WHO 2016 The Health and Social Effects of Nonmedical Cannabis Use World Health Organization International public health review of cannabis harms, including psychiatric outcomes.

Study

Marconi 2016 Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis Schizophrenia Bulletin Frequently cited meta-analysis examining dose-response patterns between cannabis use and psychosis risk.
Di Forti 2019 The Contribution of Cannabis Use to Variation in the Incidence of Psychotic Disorder Across Europe The Lancet Psychiatry Multisite case-control study assessing daily use, high-potency cannabis, and psychotic disorder incidence.

Peer Reviewed

Di Forti 2019 The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe The Lancet Psychiatry Multisite case-control study examining daily use, high-potency cannabis, and psychosis incidence.
Marconi 2016 Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis Schizophrenia Bulletin Meta-analysis assessing dose-response patterns between cannabis exposure and psychosis risk.
Murray 2017 Cannabis-associated psychosis: Neural substrate and clinical impact Neuropharmacology Review discussing possible mechanisms and clinical implications of cannabis-associated psychosis.
Volkow 2014 Adverse Health Effects of Marijuana Use New England Journal of Medicine Widely cited clinical review covering psychiatric and other health effects of cannabis use.

What each model said

Grok 4.3 Success

Cannabis use is associated with increased risk of psychotic experiences and disorders, with stronger links for frequent or high-THC use, though it is neither necessary nor sufficient to cause most cases and con...

x-ai/grok-4.3-20260430 30 May 2026 20:01 stop
OpenAI GPT-5.4 Success

Mostly true. Current evidence supports that cannabis use is associated with a higher risk of psychotic experiences and psychotic disorders, and that risk appears stronger with heavier/frequent use, earlier init...

openai/gpt-5.4-20260305 30 May 2026 20:01 stop
Mistral Medium 3.5 Success

Cannabis use is associated with an increased risk of psychotic experiences and psychotic disorders, particularly with frequent use, early initiation, and high-potency (high-THC) products. The evidence supportin...

mistralai/mistral-medium-3.5-20260430 30 May 2026 20:01 stop
Llama 4 Maverick Success

Cannabis use is associated with an increased risk of psychotic experiences and psychotic disorders, particularly with frequent use, early initiation, and high-potency products. The evidence from multiple source...

meta-llama/llama-4-maverick-17b-128e-instruct 30 May 2026 20:01 stop
Claude Opus 4.7 Success

Yes, cannabis use increases the risk of psychosis, though the relationship is probabilistic rather than deterministic and the absolute risk for any given individual remains modest. Confidence: High that an asso...

anthropic/claude-4.7-opus-20260416 30 May 2026 20:01 stop
Gemini 3.1 Pro Success

Yes, cannabis use increases the risk of developing psychosis and psychotic disorders, though it is not the sole cause of most cases. I have high confidence in the association and the dose-response relationship,...

google/gemini-3.1-pro-preview-20260219 30 May 2026 20:01 stop
Qwen 3.7 Max Success

Yes, cannabis use increases the risk of psychosis, acting as a significant contributing risk factor rather than a standalone cause. I have high confidence in this conclusion based on a broad consensus of epidem...

qwen/qwen3.7-max-20260520 30 May 2026 20:01 stop
DeepSeek V4 Pro Success

Cannabis use does increase the risk of psychosis. Confidence in this conclusion is high for an association and moderate-to-high for a causal contribution, given consistent observational and epidemiological evid...

deepseek/deepseek-v4-pro-20260423 30 May 2026 20:01 stop
GLM 5.1 Success

Cannabis use increases the risk of psychosis, particularly psychotic disorders and psychotic experiences, but it is not sufficient to explain most cases of psychosis on its own. The first two sub-claims are wel...

z-ai/glm-5.1-20260406 30 May 2026 20:01 stop
Continue browsing

Latest in Health & medicine

See all